The market performance of Cns Pharmaceuticals Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $23.90 on 03/11/24, with the lowest value for the same timeframe being $0.08, recorded on 01/29/25.
52-week price history of CNSP Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Cns Pharmaceuticals Inc’s current trading price is -99.43% away from its 52-week high, while its distance from the 52-week low is 63.11%. The stock’s price range for this period has remained between $0.08 and $23.90. The Healthcare sector company’s shares managed to surpass a trading volume of around 18.92 million for the day, which was noticeably lower compared to the shares’ average daily volume of 24.52 million over the last three months.
Financial Performance and Market Capitalization
Cns Pharmaceuticals Inc (CNSP) has experienced a quarterly rise of 9.40% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.83M and boasts a workforce of 5 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1161, with a change in price of -0.0094. Similarly, Cns Pharmaceuticals Inc recorded 23,535,332 in trading volume during the last 100 days, posting a change of -6.71%.
CNSP Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CNSP stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CNSP Stock Stochastic Average
As of today, the raw stochastic average of Cns Pharmaceuticals Inc over the past 50 days is 44.23%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 44.23%. Additionally, the Stochastic %K and %D values for the company were 50.11% and 53.29%, respectively, over the past 20 days.
CNSP Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 13.12%. However, over the past six months, we’ve seen a stronger performance of -3.40%. The price of CNSP fallen by 25.18% over the last 30 days. And in the last five days, it has surged by 31.59%.
